Expression of fibroblast activation protein in lung cancer and its correlation with tumor glucose metabolism and histopathology

被引:0
作者
Xiaohui Chen
Xinran Liu
Lijuan Wang
Wenlan Zhou
Yin Zhang
Ying Tian
Jianer Tan
Ye Dong
Lilan Fu
Hubing Wu
机构
[1] Southern Medical University,Nanfang PET Center, Nanfang Hospital
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2022年 / 49卷
关键词
Lung cancer; Fibroblast activation protein; Histopathology; Glucose metabolism; [; F] F-FDG PET/CT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2938 / 2948
页数:10
相关论文
共 61 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
de Sousa VML(2018)Heterogeneity in lung cancer Pathobiology 85 96-107
[3]  
Carvalho L(2019)Lung molecular cytopathology: EGFR and beyond J Cytol 36 124-127
[4]  
Jain D(2020)In search of definitions: cancer-associated fibroblasts and their markers Int J Cancer 146 895-905
[5]  
Nurmik M(2010)The dipeptidyl peptidase IV family in cancer and cell biology FEBS J 277 1126-1144
[6]  
Ullmann P(2017)FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression Biochem Biophys Res Commun 487 8-14
[7]  
Rodriguez F(2017)Gastric cancer in FAP: a concerning rise in incidence Fam Cancer 16 371-376
[8]  
Haan S(2004)Stromal fibroblasts in cancer initiation and progression Nature 432 332-337
[9]  
Letellier E(2014)Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy Proteomics Clin Appl 8 454-463
[10]  
Yu DM(2019)(68)Ga-FAPI PET/CT: Biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers J Nucl Med 60 386-392